Skin Diseases, Structural Biology & Crystallography - The Bunick Lab at Yale School of Medicine
October 01, 2025Information
- ID
- 13473
- To Cite
- DCA Citation Guide
Transcript
- 00:05The skin is the largest
- 00:07organ in the body. And
- 00:09not only is it a
- 00:10barrier, but it has a
- 00:11very active immune system. When
- 00:13we think of inflammatory
- 00:14skin disorders, psoriasis, when we
- 00:16think of atopic dermatitis, they
- 00:18all have a component of
- 00:19skin barrier disruption.
- 00:21And so many of the
- 00:22diseases in dermatology become a
- 00:24vicious cycle between skin barrier
- 00:26disruption and inflammation.
- 00:28Patients also experience things like
- 00:30itch,
- 00:31burning, stinging, and it affects
- 00:33their quality of life. And
- 00:35my job as the scientist
- 00:37is understanding how to break
- 00:38this loop.
- 00:46In the big picture, my
- 00:47laboratory is doing what is
- 00:48called structural biology. We are
- 00:50trying to understand the structure
- 00:52of how proteins,
- 00:54nucleic acids, and other macromolecules
- 00:56work in the skin and
- 00:58how drugs that target different
- 01:00skin diseases work. And then
- 01:02in certain genetic diseases where
- 01:04those proteins
- 01:05are in error, we want
- 01:07to understand what has gone
- 01:08wrong and how can we
- 01:09fix
- 01:11it. There's no one else
- 01:12in dermatology
- 01:13that is running a primary
- 01:14NIH funded research lab that's
- 01:17dedicated to structural biology and
- 01:19answering those difficult
- 01:20biochemistry
- 01:21questions through the approaches of
- 01:23extra crystallography,
- 01:25cryo electron microscopy, and if
- 01:27needed, nuclear magnetic resonance imaging.
- 01:33So extra crystallography
- 01:35is a particular technique that
- 01:37allows you to understand the
- 01:38atomic level structure
- 01:40of proteins, nucleic acids, and
- 01:42their complexes.
- 01:44What you have to do
- 01:44in crystallography is take a
- 01:46very pure protein, for example,
- 01:48and put it in the
- 01:49right solution
- 01:50that allows it to precipitate.
- 01:52And when it does it
- 01:53just right, it forms a
- 01:54crystal. And that crystal is
- 01:56a perfectly
- 01:58aligned lattice of lots and
- 02:00lots of molecules of that
- 02:01protein of interest. And then
- 02:03when you hit that crystal
- 02:04with x rays, that crystal
- 02:06then diffracts
- 02:07the light. And then what
- 02:09we can do is use
- 02:10mathematical
- 02:10approaches to take that diffraction
- 02:12pattern and turn it into
- 02:14actually a three-dimensional
- 02:15model
- 02:16of that protein, and that
- 02:17allows us to determine the
- 02:19structure at that atom and
- 02:20bond level. And then we
- 02:21can take that information and
- 02:23ask those critical questions. What
- 02:25does this tell us about
- 02:26helping the human patient?
- 02:33One of the wonderful things
- 02:34about being a physician scientist
- 02:36is I get to see
- 02:37what it's like in the
- 02:38lab to make a discovery,
- 02:40but I also get to
- 02:41talk to patients face to
- 02:42face. And I really get
- 02:43an understanding of what matters
- 02:45to them.
- 02:46And the advantage of this
- 02:47is it allows me to
- 02:48then come back from a
- 02:50translational perspective and understand
- 02:52what is going to help
- 02:54deliver better patient care. This
- 02:57is also why I really
- 02:58am excited to be a
- 02:59part of clinical trials here
- 03:00in dermatology
- 03:01at Yale.
- 03:03I love helping patients. I
- 03:05love it when patients feel
- 03:07better and are happier with
- 03:08themselves.
- 03:09In the end, all of
- 03:10what we do, whether it's
- 03:11the research mission,
- 03:13the clinical mission, or even
- 03:14a clinical trial mission, it's
- 03:16all about advancing patient care,
- 03:18developing new therapies for rare
- 03:20genetic skin diseases for which
- 03:22patients have nothing yet.